Ovamex 0.25 mg/0.5 ml inj. sol. s.c. pre-filled syr. Բելգիա - անգլերեն - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ovamex 0.25 mg/0.5 ml inj. sol. s.c. pre-filled syr.

theramex ireland ltd. - ganirelix acetate 0,27 mg/0,5 ml - eq. ganirelix 0,25 mg/0,5 ml - solution for injection in pre-filled syringe - ganirelix

Fyremadel 0.25 mg/0.5 mL solution for injection in prefilled syringe EFG Մալթա - անգլերեն - Medicines Authority

fyremadel 0.25 mg/0.5 ml solution for injection in prefilled syringe efg

jv healthcare limited navi buidlings, pantar road, lija, lja 2021, malta - solution for injection in pre-filled syringe - ganirelix 0.5 mg/ml - pituitary and hypothalamic hormones and analogues

Cetrotide Powder and Solvent for Solution for Powder And Solvent For Cutaneous Solution Քենիա - անգլերեն - Pharmacy and Poisons Board

cetrotide powder and solvent for solution for powder and solvent for cutaneous solution

merck (pty) ltd 1 friesland drive, longmeadow business estate - cetrorelix acetate equivalent to 0,25 mg… - powder and solvent for cutaneous solution - 0.25mg - cetrorelix

GANIRELIX TARO 0.25 MG0.5 ML Իսրայել - անգլերեն - Ministry of Health

ganirelix taro 0.25 mg0.5 ml

taro international ltd, israel - ganirelix as acetate - solution for injection - ganirelix as acetate 0.5 mg/ml - ganirelix - ganirelix taro 0.25 mg/0.5 ml is indicated for the prevention of premature luteinsing hormone (lt) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).